Related Experiment Videos

CD90 mediates gastric cancer immune evasion though regulating IGF2BP2 to stabilize the m6A-CD47/SIRPα axis

Siyi Liu1,2, Lin Liang1,2, Zihua Zhou3

  • 1Department of Nuclear Medicine, The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University/Hunan Cancer Hospital & Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China.

Insights

CD90 promotes gastric cancer immune evasion by inhibiting macrophage phagocytosis via the IGF2BP2-CD47 axis. This study reveals CD90 as a potential therapeutic target for gastric cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • CD90 (Thy-1) is a cell surface glycoprotein implicated in cancer progression.
  • Its role in gastric cancer (GC) immune evasion remains unclear.
  • Understanding CD90's function is crucial for developing novel GC therapies.

Purpose of the Study:

  • To investigate the role of CD90 in gastric cancer immune evasion.
  • To elucidate the molecular mechanisms by which CD90 mediates immune evasion.
  • To explore CD90 as a potential therapeutic target for GC.

Main Methods:

  • Analysis of CD90 expression in GC tissues.
  • Assessment of the correlation between CD90 and macrophage infiltration.
  • Investigation of CD90's effect on tumor-associated macrophage (TAM) phagocytosis.
  • Molecular experiments to determine the CD90-IGF2BP2-CD47 signaling pathway.

Main Results:

  • CD90 is highly expressed in GC tissues and correlates with macrophage infiltration.
  • CD90 inhibits TAM phagocytic function, thereby mediating immune evasion.
  • CD90 acts as a scaffold, inhibiting IGF2BP2/TRIM21 interaction and stabilizing IGF2BP2.
  • IGF2BP2 enhances CD47 mRNA stability in an m6A-dependent manner, activating the CD47/SIRPα axis.

Conclusions:

  • The CD90-IGF2BP2-CD47 axis is critical for immune evasion in gastric cancer.
  • CD90 plays a significant role in suppressing anti-tumor immunity by impairing TAM function.
  • Targeting the CD90 pathway offers a promising strategy for GC immunotherapy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...